16th Biennial International Pharmaco-EEG Group (IPEG) Congress

Thursday 7th October - Training Course programme

08:00 - 08:50 Registration Training Course
08:50 - 09:00 Opening Training Course
09:00 - 10:20 Training Course part 1

• Population PK-PD modeling applied to pharmaco EEG studies - Valle, M. (PKPD modeling and simulation, Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona, Spain)

• Preclinical use of pharmcoEEG for drug discovery: from fingerprint to biomarker - Drinkenburg, W.H.I.M. (Head Neuroscience Systems Biology, Johnson & Johnson Pharmaceutical Research and Development, Netherlands)

10:20 - 10:35 Coffee Break
10:35 - 12:45 Training Course part 2

• Technical recording aspects of translational EEG and evoked potential measurements - Ruigt, G.S.F. (Director Experimental Medicine Neuroscience, Merck & Co.)

• EEG Data Quantification, Processing and Analysis - Jobert M. (Guest Professor, University of Applied Sciences, Berlin, Germany)

• EEG neuroimaging: localization and connectivity - Pascual-Marqui, R.D. (The KEY Institute for Brain-Mind Research, University Hospital of Psychiatry Zurich, Switzerland)

12:45 - 13:45 Lunch
13:45 - 15:45 Training Course part 3

• Q-EEG in neuropsychopharmacology - from Phase I to Phase II and Beyond - Saletu, B. (Professor of Psychiatry, Section of Sleep Research and Pharmacopsychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Austria)

• Pharmaco-Sleep Studies in Man: Basics and Guideline - Anderer, P. (Associate Professor of Biomedical Engineering, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Austria)

15:45 - 16:00 Coffee Break
16:00 - 17:30 Training Course part 4

• QEEG subtyping of psychiatric disorders for prediction of outcome and treatment response - Prichep, L.S. (Brain Research Laboratories, Department of Psychiatry, New York University School of Medicine, New York, USA & Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA)

• Ethical considerations on placebo - Rosales-Rodriguez, S. (Department of Psychiatry and Psychotherapy, Medical University of Vienna, Austria)

Friday - 8th October 2010

08:00 - 09:00 Registration Symposium
09:00 - 09:30 Opening of IPEG 2010 Symposium
09:30 - 11:00 Session 1 - EEG in Drug Discovery and Development: turning curses to blessings (co-chairs: Pim Drinkenburg & Ge Ruigt )

• What can we do to unleash the potential of EEG in drug development? - F. Wilson

• EEG oscillations: A pragmatic translational measure of efficacy for drugs with antipsychotic and cognitive enhancing potential - A. Ahnaou

• A re-evaluation of construct and predictive validity for rodent counterparts to the human MMN and P300 event related potentials (ERPs) - Ed Christian

• Evaluating for QEEG biomarkers across preclinical and clinical studies: experience with orexin antagonists - S. Doran

11:00 - 11:30 Coffee Break
11:30 - 13:00 Session 2 - Influence of comorbidity and co-medication on QEEG in neuropsychiatry (co-chairs: B. Saletu & L. Prichep)

• EEG LORETA in generalized anxiety syndrome with and without non-organic insomnia - B. Saletu et al.

• Influences of co-medication on electrophysiological neuroimaging findings in Huntington's Disease - A. Painold et al.

• LORETA, atypical antipsychotics and schizophrenia - B. Kohutova (Tislerova)

13:00 - 14:00 Lunch

14:00 - 15:00 Plenary lecture: EEG neuroimaging: from localization to distributed patterns of function via generalized connectivity analysis - R.D. Pascual-Marqui

15:00 - 16:30 Session 3 - Oral communications (chair: M. Jobert)

• Evaluation of Aripiplazole effects in schizophrenia using BRL-sLORETA norms: a preliminary study - M. Yoshimura

• Investigation of effects of benzylphenylpiperazine, trifluoromethylphenylpiperazine and dexamphetamine on the event-related P300 in humans - Hee-Seung Lee

• Cordance as a biomarker in sleep-EEG for depression: differences in responders versus non-responders - a naturalistic study after antidepressant medication - M. Pawlowski

16:30 - 17:00 Coffee Break
17:00 - 18:00 General Assembly Meeting (agenda)
18:00 - 19:00 Poster Session

Saturday - 9th October 2010

09:00 - 11:00 Session 5 - EEG Based Personalized Medicine (co-chairs: U. Hegerl & M. Arns)

• Vigilance Regulation and response to psychostimulants in affective disorders - U. Hegerl

• EEG-based assessment of vigilance regulation in major depression and cancer-related fatigue - S. Olbrich

• The change of prefrontal QEEG cordance as a predictor of response to antidepressant treatment - M. Brunovsky

• An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: A pilot study - M. Arns

11:00 - 11:30 Coffe Break
11:30 - 13:00 Session 6 - Event-related potentials as a biomarker for cognitive deficits in schizophrenia and medication effects (co-chairs: T. Sumiyoshi & A. Mucci)

• ERP studies in healthy controls and cognitive effects of antipsychotics - A. Mucci

• LORETA imaging of event-related potentials to evaluate cognitive impairments of schizophrenia and effect of psychotropic drugs - T. Sumiyoshi

• Event-related potentials as a biomarker for cognitive deficits in schizophrenia and effects of medication - M. Korostenskaja

13:00 - 14:00 Lunch

14:00 - 15:00 Plenary lecture: QEEG Source Localization of the "Pain Matrix" - L.S. Prichep

15:00 - 16:30 Session 7 - Oral communications (chair: R. Luthringer)

• On the duration and processing of pharmaco-EEG recording - M. Jobert

• Benzodiazepine effects on EEG connectivity: linear and nonlinear couplings - J. F. Alonso

• EEG source analysis in obsessive-compulsive disorder - J. Koprivova

16:30 - 17:00 Coffee Break
17:00 - 18:00 Session 8 - NMDA antagonists in the animal and human models of psychosis (chair: J. Horacek)

• Comparison of animal and human EEG findings in glutamatergic models of psychosis - T. Palenicek

• The Ins and Outs of Ketamine Model of Schizophrenia: QEEG and fMRI Study in Healthy Volunteers - J. Horacek

19:00 - 02:00 Gala dinner (Kaiserstejnsky palace) 

• Distinguished lecture - C.Höschl: Bedřich Smetana, Art and Disease

• Piano Four Hands Concert (S. Pěchočová & D. Wiesner)

Sunday - 10th October 2010

09:00 - 10:30 Session 9 - New approaches in the preclinical pharmacoEEG research (chair: Pim Drinkenburg)

• Neurophysiological signals as translational biomarkers: reverse translation of endophenotypes - M. Hajos

• Behavioral and quantitative EEG changes in serotonergic and dopaminergic models of psychosis - T. Palenicek

• Orchestration of hippocampal memories by local theta oscillation - K. Jezek

10:30 - 11:00 Coffee Break
11:00 - 12:30 Session 10 - Relevance of pharmaco-EEG : a debate between academia and industry (co-chairs: B. Saletu & R. Luthringer & Ge Ruigt) (Interactive session with active participation of the audience)

12:30 Closing remarks

Thursday 7th October - Training Course
08:00 - 08:50 Registration Training Course
08:50 - 09:00 Opening Training Course
09:00 - 10:20 Training Course part 1
10:20 - 10:35 Coffee Break
10:35 - 12:45 Training Course part 2
12:45 - 13:45 Lunch
13:45 - 15:45 Training Course part 3
15:45 - 16:00 Coffee Break
16:00 - 17:30 Training Course part 4

18:00             IPEG board meeting

Friday 8th October - Symposium
08:00 - 09:00 Registration Symposium
09:00 - 09:30 Opening of Symposium
09:30 - 11:00 Session 1
11:00 - 11:30 Coffee Break
11:30 - 13:00 Session 2
13:00 - 14:00 Lunch
14:00 - 16:30 Session 3
16:30 - 17:00 Coffee Break
17:00 - 18:00 General Assembly Meeting
18:00 - 19:00 Poster Session

Saturday 9th October - Symposium
09:00 - 11:00 Session 5
11:00 - 11:30 Coffe Break
11:30 - 13:00 Session 6
13:00 - 14:00 Lunch
14:00 - 16:30 Session 7
16:30 - 17:00 Coffee Break
17:00 - 18:00 Session 8
19:00 - 02:00 Gala dinner

Sunday 10th October - Symposium
09:00 - 10:30 Session 9
10:30 - 11:00 Coffee Break
11:00 - 12:30 Session 10